CJMB CJMB
Company Profile ↓Company Overview
CJMB (CJMB) is a publicly traded company listed on . The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Recent Developments
- Dec 2025 Revenue of $5.72M (-12.8% YoY); net profit $-7.97M.
- Trailing 12 Months Year-on-year growth — revenue -12.8%.
- 5-Year Trend Long-term compounding — revenue CAGR -34.2%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | -34.16% |
| 1 Year: | -12.80% |
Stock Price Performance
| 1 Year: | -72.52% |
| 6 Months: | -37.50% |
| 3 Months: | +16.07% |
| 1 Month: | +71.50% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMABelow
- RSI (14)48.82 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
No notable strengths flagged.
CONS
- Revenue declined at -34.2% CAGR over 5 years.
- Trading 75.0% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Revenue | 1.79M | 1.99M | 1.44M | 1.45M | 1.67M | 1.45M | 1.11M |
| Gross Profit | 717.58K | 962.22K | 464.44K | 615.94K | 643.87K | 493.31K | 427.24K |
| Operating Income | -87.46K | -133.42K | -780.98K | -1.24M | -1.40M | -1.88M | -1.70M |
| Net Income | -81.13K | -112.48K | -804.99K | -1.24M | -1.40M | -2.73M | -3.22M |
| Diluted EPS | -0.03 | -0.04 | -0.27 | -0.59 | -0.31 | -0.61 | -0.32 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|
| Revenue | 13.20M | 6.56M | 5.72M |
| Gross Profit | 5.65M | 2.56M | 2.10M |
| Operating Income | 2.20M | -2.27M | -7.03M |
| Net Income | 2.18M | -2.29M | -7.97M |
| Diluted EPS | - | -0.87 | -1.82 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Total Assets | - | 9.71M | 5.08M | 5.78M |
| Total Equity | 14.01M | 8.80M | 3.17M | 2.33M |
| Cash & Equivalents | - | 5.16M | 2.10M | 2.13M |
| Total Liabilities | - | 910.27K | 1.91M | 3.45M |
| Current Liabilities | - | 769.71K | 1.27M | 1.41M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|
| Operating Cash Flow | 7.00M | 540.35K | -4.55M |
| Investing Cash Flow | -490.02K | -46.17K | -616.90K |
| Financing Cash Flow | -7.54M | -3.55M | 5.20M |
| Capital Expenditure | -490.02K | -46.17K | -616.90K |
| Free Cash Flow | 6.51M | 494.19K | -5.16M |
| Dividends Paid | 7.40M | 3.33M | - |
Ratios (Annual)
Figures in %.
| Metric | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|
| Gross Margin % | 42.8% | 39.1% | 36.8% |
| Operating Margin % | 16.7% | -34.7% | -122.9% |
| Net Margin % | 16.5% | -34.9% | -139.2% |
| ROE % | 24.8% | -72.3% | -342.2% |
| ROCE % | 24.6% | -59.7% | -161.3% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for CJMB
CJMB Stock Rockets On Alabama State Pharma Ecosystem Deal - StocksToTrade
<a href="https://news.google.com/rss/articles/CBMidkFVX3lxTE5ISDJlTG16U1FKdV90QU1qcEt1S1RXMVFQYnFXTlFucW1OVHdTZ3h0Y0NuR09seHBoT3dCU3p2Z0N3eUhVY3N3N2IxSmR4OHJCWU9uZDFFNEJ3eFlWa1pFanpmTGJaS2RCcWRoczRxWGF6X0doeHc?oc=5" target="_blank">CJMB Sto…
Callan JMB's Atlas Complex Forecast to Add 150+ High-Skilled Jobs - Stock Titan
<a href="https://news.google.com/rss/articles/CBMitwFBVV95cUxPTlhYc2dCVDJQWFFsMUJ2TFpnZ1VhLWM3Q3pkZzFWOXd2ZnN3cGRnamxnRUk5Q0czSWZVY1Q0cDExNFAzamNOQjd1RmZWZUlOVzE3WVIzN2xDWS1RVnlqcGdJaTJLRDJNVE5oN3ZiSlZReU9yV2MwU0hrcHRjVDU1Tk00X2wzazNMMk55d0…
$CJMB stock is down 27% today. Here's what we see in our data. - Quiver Quantitative
<a href="https://news.google.com/rss/articles/CBMiowFBVV95cUxPMkh1VHJ6cTRISjJJaFJVcENPY05RQWJEVk55UHowNHRZOU8ycFh0LS10ZGJMbWw2LXk1bURnQkpENDN5NlRtLXNlNklCa2J4VFpieURERkdlcGpXV29jejNNclZvb09HeEJobnZobWw2NFFyMnp3MzhiZkZ2Tk90QVMzLXFRU3RBVGY2V0…
Insiders Give Up US$84k As Callan JMB Stock Drops To US$0.79 - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMilgFBVV95cUxNT1VGTFZORUpFM1hKODhOZlA4a0s3QXdHdzk2UGdIX3ltbXZCOUxGRU9GZFpldmNkc1dncDhyYm4wLWdyTTlXYURUMy1vOWdkT1B4Vk9BLS1IZk85ZFQ3TnlSU3owNXZCUW5MNVc4dk40UXhmUGg0OXdVRG41S0VmYVJsNnVHOHNhMjNXOT…
Market Movers | Winners: SHOT, SLND, CJMB | Losers: BURU, QMLS, CYCU - Trefis
<a href="https://news.google.com/rss/articles/CBMiugFBVV95cUxOWHdyUmE1RERFLTEyVVluWkUtdTYydzh0bTd6N0lLNDByZVNyVUo1cHFtampacHdkbWx1YTA0S3dkcW1TamgtMzNtd0d0VlpKTk1XcEgxa1piUWlhVGotZDRZclQ0NEF4eEdoSVlzeDVPQklJd1ZPcG9xemVQSUJiaGVLcHdjRHpOd3pVTE…
The market is filled with gapping stocks in Friday's session. - ChartMill
<a href="https://news.google.com/rss/articles/CBMisAFBVV95cUxPN0RDUU9YM1ducWt5RUZHNENIenpQTlRibmpKdTBGdE5VZURISDgyV081Tl9Na1NudUpua0VhWV9qczNFR2RoaWhxb200d21kU1gyZC1WX0hsMDQwdzhGUWlINlMyTlJwbGRMWkc5VnJ6ZEtpRzk4SDgtWDBPV0NhTEdLa0JUM25HS3ZvOX…
CJMB — Frequently Asked Questions
What is the current share price of CJMB?
As of 2026-08-05 17:25 PDT, CJMB trades at $1.30 on NASDAQ/NYSE. Its 52-week range is $0.70 to $5.20.
What is the P/E ratio of CJMB?
CJMB trades at a trailing price-to-earnings (P/E) ratio of -0.71.
Is CJMB a good stock to buy?
This page provides a data-driven analysis of CJMB, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.